Caliber Imaging & Diagnostics, Inc. (LCDX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 15, 2025
LCDX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '14 Mar 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 |
| Revenue | 3.14 | 3.34 | 2.43 | 3.58 | 2.63 | 2.3 |
| Revenue Growth (YoY) | -1.09% | 37.24% | -31.94% | 36.17% | 14.08% | - |
| Cost of Revenue | 2.65 | 2.69 | 2.4 | 1.89 | 1.14 | 1.06 |
| Gross Profit | 0.49 | 0.65 | 0.03 | 1.69 | 1.48 | 1.24 |
| Selling, General & Admin | 4.52 | 3.98 | 5.83 | 6.8 | 4.6 | 4.11 |
| Research & Development | 1.47 | 1.53 | 3.76 | 1.46 | 0.69 | 0.76 |
| Other Operating Expenses | - | - | - | - | -0.24 | - |
| Operating Expenses | 5.99 | 5.51 | 9.6 | 8.25 | 5.04 | 4.87 |
| Operating Income | -5.5 | -4.85 | -9.57 | -6.57 | -3.56 | -3.63 |
| Interest Expense | -0.84 | -0.76 | -0.36 | -2.27 | -0.59 | -0.33 |
| Other Non Operating Income (Expenses) | 0.03 | 0.05 | 0.58 | 2.54 | -0.08 | -0.17 |
| EBT Excluding Unusual Items | -6.31 | -5.56 | -9.35 | -6.3 | -4.23 | -4.14 |
| Asset Writedown | -0.02 | - | -0.05 | - | - | - |
| Other Unusual Items | 0.08 | 0.08 | -0.42 | -2.75 | -0.08 | 0.09 |
| Pretax Income | -6.25 | -5.48 | -9.82 | -9.05 | -4.3 | -4.05 |
| Net Income | -6.25 | -5.48 | -9.82 | -9.05 | -4.3 | -4.05 |
| Preferred Dividends & Other Adjustments | - | - | - | 6.91 | - | - |
| Net Income to Common | -6.25 | -5.48 | -9.82 | -15.96 | -4.3 | -4.05 |
| Shares Outstanding (Basic) | 8 | 8 | 8 | 2 | 1 | 1 |
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 2 | 1 | 1 |
| Shares Change (YoY) | 2.92% | 4.83% | 269.58% | 62.04% | 13.34% | - |
| EPS (Basic) | -0.75 | -0.65 | -1.23 | -7.37 | -3.22 | -3.44 |
| EPS (Diluted) | -0.75 | -0.65 | -1.23 | -7.37 | -3.22 | -3.44 |
| Free Cash Flow | -4.94 | -4.86 | -7.78 | -4.62 | -4.03 | -1.46 |
| Free Cash Flow Per Share | -0.59 | -0.58 | -0.97 | -2.14 | -3.02 | -1.24 |
| Gross Margin | 15.47% | 19.57% | 1.35% | 47.15% | 56.49% | 53.78% |
| Operating Margin | -175.26% | -145.24% | -392.95% | -183.63% | -135.36% | -157.64% |
| Profit Margin | -198.99% | -163.99% | -403.38% | -446.21% | -163.81% | -175.95% |
| Free Cash Flow Margin | -157.33% | -145.60% | -319.73% | -129.29% | -153.42% | -63.21% |
| EBITDA | -5.46 | -4.82 | -9.53 | -6.56 | -3.54 | -3.48 |
| EBITDA Margin | -173.83% | -144.20% | - | -183.28% | -134.81% | -151.04% |
| D&A For EBITDA | 0.05 | 0.03 | 0.03 | 0.01 | 0.01 | 0.15 |
| EBIT | -5.5 | -4.85 | -9.57 | -6.57 | -3.56 | -3.63 |
| EBIT Margin | -175.26% | -145.24% | - | -183.63% | -135.36% | -157.64% |
| Revenue as Reported | - | - | - | 3.58 | 2.63 | 2.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.